Effectiveness of antiemetic triplet therapy with aprepitant, palonosetron, and dexamethasone for gynecologic cancer patients receiving carboplatin and paclitaxel: a prospective single-arm study

被引：0
|
作者：
Fuminori Ito
Naoto Furukawa
机构：
[1] Nara Medical University,Department of Obstetrics and Gynecology
[2] Nara Prefecture Western Medical Center,Department of Obstetrics and Gynecology
来源：
Supportive Care in Cancer | 2017年 / 25卷
关键词：
Chemotherapy-induced nausea and vomiting; Paclitaxel and carboplatin; Aprepitant; Palonosetron;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1941 / 1945
页数：4
相关论文
共 50 条
  • [41] Lower-dose apatinib combined with nanoparticle albumin-bound paclitaxel and carboplatin as a neoadjuvant regimen for triple negative breast cancer: A prospective, single-arm, phase II study
    Yin, Y.
    Li, W.
    Zha, X.
    Wang, J.
    ANNALS OF ONCOLOGY, 2020, 31 : S52 - S52
  • [42] Efficacy of aprepitant for the prevention of chemotherapy-induced nausea and vomiting with a moderately emetogenic chemotherapy regimen: a multicenter, placebo-controlled, double-blind, randomized study in patients with gynecologic cancer receiving paclitaxel and carboplatin
    Hideaki Yahata
    Hiroaki Kobayashi
    Kenzo Sonoda
    Mototsugu Shimokawa
    Tatsuhiro Ohgami
    Toshiaki Saito
    Shinji Ogawa
    Kunihiro Sakai
    Akimasa Ichinoe
    Yousuke Ueoka
    Yasuyuki Hasuo
    Makoto Nishida
    Satohiro Masuda
    Kiyoko Kato
    International Journal of Clinical Oncology, 2016, 21 : 491 - 497
  • [43] A single-arm study evaluating bevacizumab, cisplatin, and paclitaxel followed by single-agent bevacizumab in Japanese patients with advanced cervical cancer
    Sugiyama, Toru
    Mizuno, Mika
    Aoki, Yoichi
    Sakurai, Manabu
    Nishikawa, Tadaaki
    Ueda, Eisuke
    Tajima, Kosei
    Takeshima, Nobuhiro
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2017, 47 (01) : 39 - 46
  • [44] Efficacy of aprepitant for the prevention of chemotherapy-induced nausea and vomiting with a moderately emetogenic chemotherapy regimen: a multicenter, placebo-controlled, double-blind, randomized study in patients with gynecologic cancer receiving paclitaxel and carboplatin
    Yahata, Hideaki
    Kobayashi, Hiroaki
    Sonoda, Kenzo
    Shimokawa, Mototsugu
    Ohgami, Tatsuhiro
    Saito, Toshiaki
    Ogawa, Shinji
    Sakai, Kunihiro
    Ichinoe, Akimasa
    Ueoka, Yousuke
    Hasuo, Yasuyuki
    Nishida, Makoto
    Masuda, Satohiro
    Kato, Kiyoko
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2016, 21 (03) : 491 - 497
  • [45] Efficacy of palonosetron plus dexamethasone in preventing chemotherapy-induced nausea and emesis in patients receiving carboplatin-based chemotherapy for gynecologic cancers: a phase II study by the West Japan Gynecologic Oncology Group (WJGOG 131)
    Nishio, Shin
    Aihara, Satomi
    Shimokawa, Mototsugu
    Fujishita, Akira
    Taniguchi, Shuichi
    Hachisuga, Toru
    Yanazume, Shintaro
    Kobayashi, Hiroaki
    Murakami, Fumihiro
    Numa, Fumitaka
    Kotera, Kohei
    Okura, Naofumi
    Toki, Naoyuki
    Yokoyama, Masatoshi
    Ushijima, Kimio
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2018, 29 (05)
  • [46] Neoadjuvant camrelizumab, nab-paclitaxel, and carboplatin in patients with stage IB-IIIA non-small cell lung cancer (NANE-LC): a study protocol of prospective, single-arm, multicenter, phase II study
    Zhou, Haiyu
    Lin, Lili
    Qin, Tao
    Ren, Wei
    Tan, Yujie
    Yang, Qiong
    Xu, Huixin
    Xie, Xinxin
    Chen, Yongjian
    Liu, Shengbo
    Li, Xing
    Li, Zhihua
    Hu, Hai
    Yu, Yunfang
    Yao, Herui
    JOURNAL OF THORACIC DISEASE, 2021, 13 (11) : 6468 - 6475
  • [47] Salvage surgery for patients with residual disease after concurrent chemoradiation therapy for locally advanced cervical cancer: A prospective, single-arm clinical study
    Zou, Dongling
    Li, Xiuying
    GYNECOLOGIC ONCOLOGY, 2024, 190 : S265 - S265
  • [48] A single-arm phase II study of nab-paclitaxel for patients with chemorefractory non-small cell lung cancer
    Hisashi Tanaka
    Kageaki Taima
    Takeshi Morimoto
    Yoshihito Tanaka
    Masamichi Itoga
    Kunihiko Nakamura
    Akihito Hayashi
    Mika Kumagai
    Hideo Yasugahira
    Megumi Mikuniya
    Koichi Okudera
    Shingo Takanashi
    Sadatomo Tasaka
    BMC Cancer, 17
  • [49] Single-Arm Phase II Study of Nab-Paclitaxel for Patients with Chemorefractory Non-Small Cell Lung Cancer
    Tanaka, Hisashi
    Taima, Kageaki
    Morimoto, Takeshi
    Tanaka, Yoshihito
    Itoga, Masamichi
    Nakamura, Kunihiko
    Hayashi, Akihito
    Kumagai, Mika
    Yasugahira, Hideo
    Mikuniya, Megumi
    Okudera, Koichi
    Takanashi, Shingo
    Tasaka, Sadatomo
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S922 - S922
  • [50] PRIMARY RESULTS FROM ROSIA, A SINGLE-ARM STUDY EVALUATING EXTENDED DURATION OF BEVACIZUMAB COMBINED WITH FRONT-LINE CARBOPLATIN AND PACLITAXEL FOR EPITHELIAL OVARIAN CANCER
    Colombo, N.
    Davidenko, I.
    Korach, J.
    Mendiola, C.
    Selle, F.
    Ghatage, P.
    Ottesen, S.
    Ngan, H.
    De Giorgi, U.
    Alberto Hernandez, C.
    Wei, L. H.
    Chuang, C. M.
    Chou, H. H.
    Revil, C.
    Robb, S.
    Dolado, I.
    Oza, A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (09) : 27 - 30
12345